Blazar BR - Search Results

1

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression.

Osborn MJ, Lees CJ, McElroy AN, Merkel SC, Eide CR, Mathews W, Feser CJ, Tschann M, McElmury RT, Webber BR, Kim CJ, Blazar BR, Tolar J. Osborn MJ, et al. Among authors: blazar br. Int J Mol Sci. 2018 Mar 22;19(4):946. doi: 10.3390/ijms19040946. Int J Mol Sci. 2018. PMID: 29565806 Free PMC article.

2

A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.

Chan CH, Blazar BR, Eide CR, Kreitman RJ, Vallera DA. Chan CH, et al. Among authors: blazar br. Blood. 1995 Oct 1;86(7):2732-40. Blood. 1995. PMID: 7670112 Free article.

3

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.

Vallera DA, Panoskaltsis-Mortari A, Jost C, Ramakrishnan S, Eide CR, Kreitman RJ, Nicholls PJ, Pennell C, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1996 Sep 15;88(6):2342-53. Blood. 1996. PMID: 8822957 Free article.

4

Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.

Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S, Lees C, Waldschmidt T, Vallera DA. Blazar BR, et al. Blood. 1998 Nov 15;92(10):3949-59. Blood. 1998. PMID: 9808589 Free article.

5

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA. Blazar BR, et al. J Immunol. 2000 Nov 1;165(9):4901-9. doi: 10.4049/jimmunol.165.9.4901. J Immunol. 2000. PMID: 11046015

6

Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.

Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2001 Jul 15;98(2):467-74. doi: 10.1182/blood.v98.2.467. Blood. 2001. PMID: 11435318 Free article.

7

Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.

Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 Mar 1;99(5):1870-2. doi: 10.1182/blood.v99.5.1870. Blood. 2002. PMID: 11861310 Free article.

8

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Taylor PA, Lees CJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 May 15;99(10):3493-9. doi: 10.1182/blood.v99.10.3493. Blood. 2002. PMID: 11986199 Free article.

9

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. Wagner JE, et al. Among authors: blazar br. Blood. 2002 Sep 1;100(5):1611-8. doi: 10.1182/blood-2002-01-0294. Blood. 2002. PMID: 12176879 Free article.

10

Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.

Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 Nov 1;100(9):3400-7. doi: 10.1182/blood-2002-03-0872. Blood. 2002. PMID: 12384443 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

888 results

Search Page